期刊文献+

电子阴道镜与人乳头状瘤病毒高危型检测在宫颈癌前病变防治中的价值 被引量:4

Value of colposcopy combined with detection of high-oncogenic risk HPV in the prevention and treatment of preinvasive disease of the cervix
下载PDF
导出
摘要 目的通过对阴道镜检查宫颈上皮内瘤样病变(CIN),即宫颈癌前病变,以及HPV16、18型与CIN关系的研究,探讨阴道镜结合HPV16、18在宫颈癌前病变防治中的价值。方法采用电子阴道镜观察宫颈形态、免疫组织化学法检测宫颈组织中HPV16、18,并与病理检查结果对照分析。结果阴道镜诊断CIN的灵敏度为57.5%,特异度为83.2%,阳性预测值67.1%;HPV16、18阳性病例中CIN的发生率显著高于阴性病例,HPV16、18的检出率随CINⅠ级、CINⅡ、Ⅲ级和宫颈鳞癌病变程度的加重而增高(P<0.05)。结论阴道镜指引下能准确选择CIN病变活检定位;HPV16、18检测可作为协助诊断CIN的方法之一,与阴道镜结合可提高宫颈癌前病变防治的准确率。 【Objective】To evaluate the value of colposcopy combined with detection HPV16, 18 in the preven- tion and treatment of cervical intraepithelial neoplasia (CIN), as the same as the preinvasive disease of the cervix. 【Methods】Colposcopy was used to examine cervix uteri, and immunohistochemical (IHC) staining (S-P) was em- ployed to test HPV 16, 18 DNA. 【Results】The sensitivity of colposcopy in diagnosing CIN was 57.5%, with the specificity being 83.2%, and the positive predictive value was 67.1%. The accuracy ...
出处 《中国内镜杂志》 CSCD 北大核心 2008年第11期1218-1220,1223,共4页 China Journal of Endoscopy
关键词 阴道镜 HPV高危型 宫颈癌前病变 防治 colposcopy high-oncogenic risk HPV cervical intraepithelial neoplasia prevention and treatment
  • 相关文献

参考文献4

二级参考文献14

  • 1钟雪辉,胡丽芳.阴道镜检查265例临床分析[J].中国内镜杂志,2005,11(5):522-523. 被引量:5
  • 2冯文曦,梅玲,王宁,郑红.荧光定量PCR技术检测尖锐湿疣患者人乳头瘤病毒感染的结果分析[J].第三军医大学学报,2005,27(13):1366-1366. 被引量:8
  • 3郎景和 见:沈铿 郎景和 主编.子宫颈病变诊断与治疗规范化的建议[A].见:沈铿,郎景和,主编.妇科肿瘤面临的问题和挑战[C].北京:人民卫生出版社,2002.37~43.
  • 4张志胜主编.阴道镜图谱[M].北京:人民卫生出版社,2000.45.
  • 5LONKY NM, SADEGHI M, TSADIK GM, et al. The clinical significance of the poor correlation of cervical dysplasia and cervical malignancy with referral cytalogic results[J]. Am Journal of Obstetric and Gynecology, 1991, 181: 560-566.
  • 6American College of Obstetricians and Gynecologists. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 61, April 2005. Human papillomavirus[J]. Obstetric and Gynecology, 2005, 105(4): 905-918.
  • 7Pagliusi SR,Aguado MT.Efficacy and other milestones for human papillomavirus vaccine introduction.Vaccine,2004,23:569-578.
  • 8Shin HR,Lee DH,Herrero R,et al.Prevalence of human papillomavirus infection in woman in Busan,South Korea.Int J Cancer,2003,103:413-421.
  • 9Ferrera A,Velema J P,Figueroa M,et al.Human papillomavirus infection,cervical dysplasia and invasive cervical cancer in Honduras:a case-control study.Int J Cancer,1999,82:79.
  • 10Meijer CJL,RozendaalL,van derL inden JC.Human papillomavirus testing for primary cervical cancer screening.In:Franco E,Monsenego J,eds.New Developments in Cervical Cancer Screening and Prevention.Oxford:Blackwell Science,1997.338-347.

共引文献233

同被引文献62

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部